All Type of News
Korea’s drug spending is high in OECD nations
Korea’s medication spending on health showed a higher share among 30 Organization for Economic Cooperation and Development (OECD) member countries, the Ministry of Health and Welfare said on July 23.
According to t...
ViroMed receives US FDA Approval of Phase II trial for VM202
ViroMed Co., a local pharmaceutical firm, announced on July 21 that VM202-PAD, the company’s proprietary DNA medicine for the treatment of peripheral artery disease (PAD), has received approval from the US Food and Dr...
KGC signs ginseng export deal
Korea Ginseng Corporation (KTC) has signed a contract with a Saudi Arabian Company to export its red ginseng extract.
The deal with AL MUTAWA group in the scale of $20 million was made available after acquiring GMP...
Hanmi exports combo drug to overseas markets
Local drug maker Hanmi Pharm said on July 20 that it will export its independently developed incrementally modified drug (IMD) to overseas markets through a multinational pharmaceutical company.
The company said on...
KFDA to ameliorate biosimilar related rules
The Korea Food and Drug Administration has recently unveiled its plan to effectively implement the recently updated biosimilar regulations as part of efforts to promote local biosimilar business.
The drug agency sa...
Government to raise NovoSeven insurance price by 35% on average
The government said on July 21 that the insurance price of Novo Nordisk’s NovoSeven will increase by 35% on average, as the health ministry and Novo Nordisk reached an agreement over the controversial price negotiatio...
Green Cross likely to supply 12 million doses of flu A vaccines
Although health authorities downplay the worries about the H1N1 flu, stressing that the virus presently remains in a mild form, the continuing spread of influenza A, still in the early stages of the outbreak, has crit...
Macrogen to sequence Asian gene map
Macrogen Inc. Chairman Suh Jung-sun said on July 20 that the company will conduct the sequencing of the Asian gene map in collaboration with the government and private organizations.
He added that the job will be c...
40% of 10 Koreans suffer abdominal pain
About 40 percent of 10 Korean people are said to experience abdominal disorders (pain, discomfort or spasm) once a year, according to a recent survey of 1,000 adults, conducted by Boehringer Ingelheim Korea.
53.8 p...
Dong-A’s Stillen enjoys robust sales in first half
Dong-A Pharm says its Stillen garnered 40 billion won in the domestic ulceration drug market for the January-June period of this year, up a whopping 145 percent compared with the same period a year earlier.
The mar...
